Potential of semen coicis in enhancing the anti-tumor effects of PD-1 inhibitor on A549 cell lines by blocking the PI3K-AKT-mTOR pathway

被引:0
|
作者
Fu, Zi-Yi [1 ]
Huang, Ying [2 ]
Lian, Le-Shen [3 ]
Huang, Hui-Ting [4 ]
Zhan, Shao-Feng [4 ]
Cai, Yan [2 ]
Li, Jun-Xiong [5 ]
Liu, Xiao-Hong [4 ]
机构
[1] Guangzhou Univ Chinese Med, Clin Med Sch 1, Guangzhou 510000, Peoples R China
[2] Guangzhou Univ Chinese Med, Affiliated Hosp 2, Dept Pulm & Crit Care Med, Guangzhou 510000, Peoples R China
[3] Guangzhou Univ Chinese Med, Dept Pulm & Crit Care Med, Dongguan Hosp, Dongguan 523000, Peoples R China
[4] Guangzhou Univ Chinese Med, Dept Pulm & Crit Care Med, Affiliated Hosp 1, Guangzhou 510000, Peoples R China
[5] Guangdong Prov Hosp Integrated Tradit Chinese & We, Dept Pulm & Crit Care Med, Foshan 528000, Peoples R China
来源
CLINICAL & TRANSLATIONAL ONCOLOGY | 2024年 / 26卷 / 09期
关键词
A549; cell; Network pharmacology; PD-1; inhibitor; PI3K-AKT-mTOR signal pathway; Semen coicis; TUMOR-NECROSIS-FACTOR; GAMMA;
D O I
10.1007/s12094-024-03444-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundThe objective of this research was to investigate how the combination of semen coicis extract and PD-1 inhibitors can potentially work together to enhance the anti-tumor effects, with a focus on understanding the underlying mechanism.MethodsWe obtained the active components and specific targets of semen coicis in the treatment of NSCLC from various databases, namely TCMSP, GeneCard, and OMIM. By utilizing the STRING database and Cytoscape software, we established a protein interaction network (PPI) for the active ingredient of semen coicis and the target genes related to NSCLC. To explore the potential pathways involved, we conducted gene ontology (GO) and biological pathway (KEGG) enrichment analyses, which were further supported by molecular docking technology. Additionally, we conducted cyto-inhibition experiments to verify the inhibitory effects of semen coicis alone or in combination with a PD-1 inhibitor on A549 cells, along with examining the associated pathways. Furthermore, we investigated the synergistic mechanism of these two drugs through cytokine release experiments and the PD-L1 expression study on A549 cells.ResultsSemen coicis contains two main active components, Omaine and (S)-4-Nonanolide. Its primary targets include PIK3R1, PIK3CD, PIK3CA, AKT2, and mTOR. Molecular docking experiments confirmed that these ingredients and targets form stable bonds. In vitro experiments showed that semen coicis demonstrates inhibitory effects against A549 cells, and this effect was further enhanced when combined with PD-1 inhibitors. PCR and WB analysis confirmed that the inhibition of the PI3K-AKT-mTOR pathway may contribute to this effect. Additionally, semen coicis was observed to decrease the levels of IFN-gamma, IL-6, and TNF-alpha, promoting the recovery of the human anti-tumor immune response. And semen coicis could inhibit the induced expression of PD-L1 of A549 cells stimulated by IFN-gamma as well.ConclusionSemen coicis not only has the ability to kill tumor cells directly but also alleviates the immunosuppression found in the tumor microenvironment. Additionally, it collaboratively enhances the effectiveness of PD-1 inhibitors against tumors by blocking the activation of PI3K-AKT-mTOR.
引用
收藏
页码:2250 / 2261
页数:12
相关论文
共 50 条
  • [1] The Role of the PI3K-AKT-mTOR Pathway in NK Cell Anti-Tumor Reactivity.
    Krusch, Matthias
    Salih, Julia
    Kumbier, Ingrid
    Fenner, Carolin
    Kanz, Lothar
    Salih, Helmut R.
    BLOOD, 2009, 114 (22) : 1421 - 1421
  • [2] NK Cell Anti-Tumor Reactivity Is Indluenced by the PI3K-AKT - mTOR Pathway
    Krusch, M.
    Salih, J.
    Fenner, C.
    Kumbier, I.
    Kanz, L.
    Salih, H. R.
    ONKOLOGIE, 2010, 33 : 157 - 157
  • [3] Inhibition of PI3K-AKT-mTOR pathway sensitizes endometrial cancer cell lines to PARP inhibitors
    Charles-André Philip
    Ido Laskov
    Marie-Claude Beauchamp
    Maud Marques
    Oreekha Amin
    Joanna Bitharas
    Roy Kessous
    Liron Kogan
    Tahira Baloch
    Walter H. Gotlieb
    Amber Yasmeen
    BMC Cancer, 17
  • [4] Inhibition of PI3K-AKT-mTOR pathway sensitizes endometrial cancer cell lines to PARP inhibitors
    Philip, Charles-Andre
    Laskov, Ido
    Beauchamp, Marie-Claude
    Marques, Maud
    Amin, Oreekha
    Bitharas, Joanna
    Kessous, Roy
    Kogan, Liron
    Baloch, Tahira
    Gotlieb, Walter H.
    Yasmeen, Amber
    BMC CANCER, 2017, 17
  • [5] TEEG Induced A549 Cell Autophagy by Regulating the PI3K/AKT/mTOR Signaling Pathway
    Shi, Lu
    Tu, Yijun
    Xia, Yu
    Ye, Siqi
    Ma, Chaozhi
    Liu, Yanwen
    You, Pengtao
    ANALYTICAL CELLULAR PATHOLOGY, 2019, 2019
  • [6] Anti-tumor efficacy of phellamurin in osteosarcoma cells: Involvement of the PI3K/AKT/mTOR pathway
    Zhang, Hongzhi
    Jiang, Huijuan
    Zhang, Huixiang
    Liu, Juncai
    Hu, Xigang
    Chen, Lei
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2019, 858
  • [7] Tanshinone IIA affects the proliferation of A549/Tax by affecting the expression of MMP7 through the PI3K-AKT-mTOR signaling pathway
    Chen, Fangjun
    Xiang, Wenqiong
    Qiang, Guangliang
    DISCOVER ONCOLOGY, 2025, 16 (01)
  • [8] Cabazitaxel-induced autophagy via the PI3K/Akt/mTOR pathway contributes to A549 cell death
    Huo, Ruichao
    Wang, Lili
    Liu, Peijuan
    Zhao, Yong
    Zhang, Caiqin
    Bai, Bing
    Liu, Xueying
    Shi, Changhong
    Wei, Sanhua
    Zhang, Hai
    MOLECULAR MEDICINE REPORTS, 2016, 14 (04) : 3013 - 3020
  • [9] Radiation and PI3K-ad inhibitor enhanced anti-tumor effect of PD-1 blockade in syngeneic tumor model
    Kim, I. A.
    Park, J. M.
    Lee, J. H.
    Kim, D.
    Lim, Y.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S72 - S72
  • [10] Cyclophilin A inhibits A549 cell oxidative stress and apoptosis by modulating the PI3K/Akt/mTOR signaling pathway
    Ma, Zhenling
    Zhang, Wenwen
    Wu, Yaru
    Zhang, Menghao
    Wang, Lei
    Wang, Yihan
    Wang, Yi
    Liu, Wei
    BIOSCIENCE REPORTS, 2021, 41 (01)